RECORDATI INDUSTRIA CHIMICA (REC.MI) Stock Fundamental Analysis

BIT:REC • IT0003828271

48.18 EUR
0 (0%)
Last: Feb 23, 2026, 10:10 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall REC gets a fundamental rating of 4 out of 10. We evaluated REC against 52 industry peers in the Pharmaceuticals industry. While REC is still in line with the averages on profitability rating, there are concerns on its financial health. REC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year REC was profitable.
  • In the past year REC had a positive cash flow from operations.
  • REC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years REC had a positive operating cash flow.
REC.MI Yearly Net Income VS EBIT VS OCF VS FCFREC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

  • REC has a Return On Assets (7.63%) which is in line with its industry peers.
  • REC has a Return On Equity of 20.98%. This is in the better half of the industry: REC outperforms 69.23% of its industry peers.
  • With a decent Return On Invested Capital value of 12.30%, REC is doing good in the industry, outperforming 61.54% of the companies in the same industry.
  • REC had an Average Return On Invested Capital over the past 3 years of 12.56%. This is in line with the industry average of 14.12%.
Industry RankSector Rank
ROA 7.63%
ROE 20.98%
ROIC 12.3%
ROA(3y)8.39%
ROA(5y)10.39%
ROE(3y)21.82%
ROE(5y)24.25%
ROIC(3y)12.56%
ROIC(5y)14.53%
REC.MI Yearly ROA, ROE, ROICREC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With a decent Profit Margin value of 15.83%, REC is doing good in the industry, outperforming 67.31% of the companies in the same industry.
  • In the last couple of years the Profit Margin of REC has declined.
  • The Operating Margin of REC (26.48%) is better than 63.46% of its industry peers.
  • In the last couple of years the Operating Margin of REC has declined.
  • REC has a Gross Margin of 67.66%. This is comparable to the rest of the industry: REC outperforms 44.23% of its industry peers.
  • REC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.48%
PM (TTM) 15.83%
GM 67.66%
OM growth 3Y-4.02%
OM growth 5Y-2.11%
PM growth 3Y-10.03%
PM growth 5Y-6.5%
GM growth 3Y-2.14%
GM growth 5Y-0.62%
REC.MI Yearly Profit, Operating, Gross MarginsREC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so REC is still creating some value.
  • REC has about the same amout of shares outstanding than it did 1 year ago.
  • REC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, REC has a worse debt to assets ratio.
REC.MI Yearly Shares OutstandingREC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REC.MI Yearly Total Debt VS Total AssetsREC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • REC has an Altman-Z score of 3.48. This indicates that REC is financially healthy and has little risk of bankruptcy at the moment.
  • REC has a Altman-Z score (3.48) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.14 is on the high side and indicates that REC has dependencies on debt financing.
  • REC's Debt to Equity ratio of 1.14 is on the low side compared to the rest of the industry. REC is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Altman-Z 3.48
ROIC/WACC1.58
WACC7.78%
REC.MI Yearly LT Debt VS Equity VS FCFREC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • REC has a Current Ratio of 1.64. This is a normal value and indicates that REC is financially healthy and should not expect problems in meeting its short term obligations.
  • REC's Current ratio of 1.64 is fine compared to the rest of the industry. REC outperforms 65.38% of its industry peers.
  • A Quick Ratio of 1.16 indicates that REC should not have too much problems paying its short term obligations.
  • REC has a better Quick ratio (1.16) than 67.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.16
REC.MI Yearly Current Assets VS Current LiabilitesREC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.34% over the past year.
  • The Earnings Per Share has been growing slightly by 2.74% on average over the past years.
  • REC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.58%.
  • Measured over the past years, REC shows a quite strong growth in Revenue. The Revenue has been growing by 9.58% on average per year.
EPS 1Y (TTM)0.34%
EPS 3Y3.03%
EPS 5Y2.74%
EPS Q2Q%-2.03%
Revenue 1Y (TTM)12.58%
Revenue growth 3Y14.01%
Revenue growth 5Y9.58%
Sales Q2Q%13.44%

3.2 Future

  • REC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.13% yearly.
  • The Revenue is expected to grow by 8.40% on average over the next years. This is quite good.
EPS Next Y4.53%
EPS Next 2Y8.6%
EPS Next 3Y10.16%
EPS Next 5Y12.13%
Revenue Next Year12.79%
Revenue Next 2Y9.64%
Revenue Next 3Y8.87%
Revenue Next 5Y8.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REC.MI Yearly Revenue VS EstimatesREC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
REC.MI Yearly EPS VS EstimatesREC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 24.58, REC is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as REC.
  • REC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • REC is valuated correctly with a Price/Forward Earnings ratio of 16.61.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of REC indicates a somewhat cheap valuation: REC is cheaper than 67.31% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.02. REC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.58
Fwd PE 16.61
REC.MI Price Earnings VS Forward Price EarningsREC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • REC's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.83
REC.MI Per share dataREC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.43
PEG (5Y)8.99
EPS Next 2Y8.6%
EPS Next 3Y10.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • REC has a Yearly Dividend Yield of 2.67%.
  • REC's Dividend Yield is a higher than the industry average which is at 1.89.
  • REC's Dividend Yield is a higher than the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.67%

5.2 History

  • The dividend of REC has a limited annual growth rate of 5.70%.
Dividend Growth(5Y)5.7%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • REC pays out 64.79% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of REC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP64.79%
EPS Next 2Y8.6%
EPS Next 3Y10.16%
REC.MI Yearly Income VS Free CF VS DividendREC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
REC.MI Dividend Payout.REC.MI Dividend Payout, showing the Payout Ratio.REC.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

RECORDATI INDUSTRIA CHIMICA

BIT:REC (2/23/2026, 10:10:08 AM)

48.18

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-17
Earnings (Next)05-12
Inst Owners31.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.08B
Revenue(TTM)2.55B
Net Income(TTM)404.39M
Analysts74.67
Price Target59.62 (23.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.67%
Yearly Dividend1.23
Dividend Growth(5Y)5.7%
DP64.79%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.85%
PT rev (3m)-1.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE 24.58
Fwd PE 16.61
P/S 3.94
P/FCF N/A
P/OCF 18.67
P/B 5.23
P/tB N/A
EV/EBITDA 13.83
EPS(TTM)1.96
EY4.07%
EPS(NY)2.9
Fwd EY6.02%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)2.58
OCFY5.36%
SpS12.22
BVpS9.22
TBVpS-6.12
PEG (NY)5.43
PEG (5Y)8.99
Graham Number20.16
Profitability
Industry RankSector Rank
ROA 7.63%
ROE 20.98%
ROCE 15.9%
ROIC 12.3%
ROICexc 13.83%
ROICexgc 88.81%
OM 26.48%
PM (TTM) 15.83%
GM 67.66%
FCFM N/A
ROA(3y)8.39%
ROA(5y)10.39%
ROE(3y)21.82%
ROE(5y)24.25%
ROIC(3y)12.56%
ROIC(5y)14.53%
ROICexc(3y)13.61%
ROICexc(5y)15.94%
ROICexgc(3y)107.06%
ROICexgc(5y)120.52%
ROCE(3y)16.51%
ROCE(5y)18.96%
ROICexgc growth 3Y-16.79%
ROICexgc growth 5Y-5.99%
ROICexc growth 3Y-13.14%
ROICexc growth 5Y-5.73%
OM growth 3Y-4.02%
OM growth 5Y-2.11%
PM growth 3Y-10.03%
PM growth 5Y-6.5%
GM growth 3Y-2.14%
GM growth 5Y-0.62%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF N/A
Debt/EBITDA 2.51
Cap/Depr 439.85%
Cap/Sales 34.13%
Interest Coverage 7.09
Cash Conversion 61.7%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.16
Altman-Z 3.48
F-Score5
WACC7.78%
ROIC/WACC1.58
Cap/Depr(3y)284.95%
Cap/Depr(5y)216.99%
Cap/Sales(3y)19.98%
Cap/Sales(5y)14.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.34%
EPS 3Y3.03%
EPS 5Y2.74%
EPS Q2Q%-2.03%
EPS Next Y4.53%
EPS Next 2Y8.6%
EPS Next 3Y10.16%
EPS Next 5Y12.13%
Revenue 1Y (TTM)12.58%
Revenue growth 3Y14.01%
Revenue growth 5Y9.58%
Sales Q2Q%13.44%
Revenue Next Year12.79%
Revenue Next 2Y9.64%
Revenue Next 3Y8.87%
Revenue Next 5Y8.4%
EBIT growth 1Y6.12%
EBIT growth 3Y9.43%
EBIT growth 5Y7.27%
EBIT Next Year43.18%
EBIT Next 3Y18.7%
EBIT Next 5Y14.97%
FCF growth 1Y-349.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.9%
OCF growth 3Y5.01%
OCF growth 5Y12.33%

RECORDATI INDUSTRIA CHIMICA / REC.MI FAQ

What is the ChartMill fundamental rating of RECORDATI INDUSTRIA CHIMICA (REC.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to REC.MI.


What is the valuation status of RECORDATI INDUSTRIA CHIMICA (REC.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to RECORDATI INDUSTRIA CHIMICA (REC.MI). This can be considered as Overvalued.


How profitable is RECORDATI INDUSTRIA CHIMICA (REC.MI) stock?

RECORDATI INDUSTRIA CHIMICA (REC.MI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for REC stock?

The Price/Earnings (PE) ratio for RECORDATI INDUSTRIA CHIMICA (REC.MI) is 24.58 and the Price/Book (PB) ratio is 5.23.


Can you provide the financial health for REC stock?

The financial health rating of RECORDATI INDUSTRIA CHIMICA (REC.MI) is 3 / 10.